Analyst Recommendations

B. Riley Securities analyst issues BUY recommendation for BLZE on February 9, 2024 12:00PM ET. The previous analyst recommendation was Buy.BLZE was trading at $9.1 at issue of...

February 9, 2024   BLZE -3.16%

RBC Capital analyst issues UNDERPERFORM recommendation for MAA on February 9, 2024 12:00PM ET. The previous analyst recommendation was Underperform.MAA was trading at $123.9075 at issue of the...

February 9, 2024   MAA -0.23%

Scotiabank analyst issues SECTOR PERFORM recommendation for MAA on February 9, 2024 12:00PM ET. The previous analyst recommendation was Sector Perform.MAA was trading at $123.9075 at issue of...

February 9, 2024   MAA -0.23%

Piper Sandler analyst issues NEUTRAL recommendation for LSPD on February 9, 2024 12:00PM ET. The previous analyst recommendation was Neutral.LSPD was trading at $14.47 at issue of the...

February 9, 2024   LSPD 0.22%

Piper Sandler analyst issues UNDERPERFORM recommendation for ROE on February 9, 2024 12:00PM ET. The previous analyst recommendation was Underperform.ROE was trading at $0 at issue of the...

February 9, 2024   ROE -0.50%

Piper Sandler analyst issues UNDERWEIGHT recommendation for AFRM on February 9, 2024 12:12PM ET. The previous analyst recommendation was Underweight.AFRM was trading at $43.39 at issue of the...

February 9, 2024   AFRM -2.70%

Stephens analyst issues UNDERWEIGHT recommendation for AFRM on February 9, 2024 12:12PM ET. The previous analyst recommendation was Underweight.AFRM was trading at $43.3897 at issue of the analyst...

February 9, 2024   AFRM -2.70%

Wedbush analyst issues OUTPERFORM recommendation for CXW on February 9, 2024 12:00PM ET. The previous analyst recommendation was Outperform.CXW was trading at $14.735 at issue of the analyst...

February 9, 2024   CXW -0.86%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for DOCS on February 9, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight.DOCS was trading at $28.862 at issue of the...

February 9, 2024   DOCS -1.13%

Goldman Sachs analyst issues BUY recommendation for INTR on February 9, 2024 12:00PM ET. The previous analyst recommendation was Buy.INTR was trading at $5.475 at issue of the...

February 9, 2024   INTR -0.50%